M&T Bank’s Array Biopharma Inc ARRY Stock Holding History

M&T Bank’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,189	Closed	-$49K	–	2189
2014 Q4	$49K	Buy	10,189 +125	+1%	+$494	﹤0.01%	1928
2014 Q3	$35K	Buy	+10,064	New	+$39.7K	﹤0.01%	2115

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

M&T Bank's ARRY Position: Q1 2015 in Review

M&T Bank sold out of Array Biopharma Inc (ARRY) in Q1 2015, closing a stake of 10,189 shares — an estimated $49K sold.

M&T Bank first reported a position in ARRY in Q3 2014 and held it in 2 quarters. The position peaked at $49K in Q4 2014. 133 funds tracked by Wall St. Rank hold ARRY as of Q1 2015.

M&T Bank reported no remaining Array Biopharma Inc position as of Q1 2015 after selling out during the quarter.
M&T Bank sold 10,189 Array Biopharma Inc shares in Q1 2015, an estimated $49K.
M&T Bank first reported a position in Array Biopharma Inc in Q3 2014 and held it in 2 quarters.
M&T Bank's Array Biopharma Inc position peaked at $49K in Q4 2014.
133 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2015.

Based on M&T Bank's 13F filing for Q1 2015, filed 14 May 2015.